Product NDC: | 60977-001 |
Proprietary Name: | Phenergan |
Non Proprietary Name: | PROMETHAZINE HYDROCHLORIDE |
Active Ingredient(s): | 25 mg/mL & nbsp; PROMETHAZINE HYDROCHLORIDE |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 60977-001 |
Labeler Name: | Baxter Healthcare Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA083312 |
Marketing Category: | ANDA |
Start Marketing Date: | 20091210 |
Package NDC: | 60977-001-01 |
Package Description: | 25 AMPULE in 1 PACKAGE (60977-001-01) > 1 mL in 1 AMPULE (60977-001-43) |
NDC Code | 60977-001-01 |
Proprietary Name | Phenergan |
Package Description | 25 AMPULE in 1 PACKAGE (60977-001-01) > 1 mL in 1 AMPULE (60977-001-43) |
Product NDC | 60977-001 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | PROMETHAZINE HYDROCHLORIDE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20091210 |
Marketing Category Name | ANDA |
Labeler Name | Baxter Healthcare Corporation |
Substance Name | PROMETHAZINE HYDROCHLORIDE |
Strength Number | 25 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Phenothiazine [EPC],Phenothiazines [Chemical/Ingredient] |